Stem cell research offers hope for Visio-patients (Reuters)
Maggie Fox, health and Science Editor Maggie Fox, health and Science Editor – Mon Nov 22 6 : 19 pm ET, WASHINGTON (Reuters)-Portland, Oregon, Christopher Goodrich can be expected to stick a needle in her eye. Goodrich hopes one clinical research, which received only in the food and drug administration, only the second research accepted throughout the world to test the human embryonic stem cells in humans, the go-ahead of the first patients enrolled in. Advanced cell technology, a small Massachusetts-based biotechnology company, which has struggled to raise the human embryonic stem cell Lab clinic begins recruitment and Massachusetts patients 12 Oregon rare eye condition, i.e. Stargardt's macular dystrophy. Goodrich, 55, retired last year in his job as a coordinator of Portland State University services veteran's macular dystrophy when his Stargardt viewing experience, and suddenly deteriorated. Like most patients Goodrich had seen his Vision to get steadily worse his young adul...